ScholarIQanswers from OpenAlex

Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro

PaperCitations, authors & open-access status

Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro have?

ScholarIQcitation count

Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro has 167 citations in the OpenAlex counts ScholarIQ stores.

When was Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro published?

ScholarIQyear

Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro has 1986 year in the ScholarIQ index.

What is the open-access status of Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro?

ScholarIQoa status

Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro has closed oa status in the ScholarIQ index.

What is the DOI of Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro?

ScholarIQdoi

The DOI for Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro is on the source record.

What is the PMID of Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro?

ScholarIQpmid

The PMID for Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro is on the source record.

What is the OpenAlex record for Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro?

ScholarIQopenalex

The OpenAlex for Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial